Loading
Latest filing published 27 Apr 2026 for MicroPort CardioFlow Medtech Corporation - B.
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Zhang Ruinian (chief executive) discloses dealings in MicroPort CardioFlow Medtech Corporation - B to HKEX. Over a trading history stretching from 28 March 2025 to 31 March 2026, the count stands at 3 filings.
On the market, this insider has only ever bought: 3 purchases, €8,480 in total. The amount is not disclosed for 2 filings. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2026, the count stands at 1 purchase and no sales.
On 27 April 2026 came the latest disclosure, an open-market purchase in MicroPort CardioFlow Medtech Corporation - B. The median gap between a trade and its publication by HKEX is 5 days. This delay matters because a trade only becomes useful information once it is public. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration